The renin rise with aliskiren: It's simply stoichiometry

Hypertension

Volumn 51, Issue 4, 2008, Pages

  Jan Danser, A H ^a   Charney, Alan ^b   Feldman, David L ^b   Nussberger, Juerg ^c   Fisher, Naomi ^d   Hollenberg, Norman ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NOVARTIS PHARMA AG   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALISKIREN; ANGIOTENSIN; RENIN; SODIUM; AMIDE; ANTIHYPERTENSIVE AGENT; FUMARIC ACID DERIVATIVE;

BLOOD PRESSURE MEASUREMENT; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; HUMAN; IC 50; LETTER; NORMAL HUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM RESTRICTION; STEADY STATE; STOICHIOMETRY; TREATMENT DURATION; BLOOD; HYPERTENSION; METABOLISM; NOTE;

AMIDES; ANTIHYPERTENSIVE AGENTS; FUMARATES; HUMANS; HYPERTENSION; RENIN;

EID: 42049104395     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.109967     Document Type: Letter

References (5)